Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 2070.SR · as of 2026-06-15
Financial statements
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.71B | $1.68B | $1.65B | $1.43B | $1.46B |
| Cost of Revenue | $0.91B | $0.84B | $0.94B | $0.86B | $0.84B |
| Gross Profit | $0.79B | $0.84B | $0.71B | $0.57B | $0.62B |
| Gross Margin %(computed) | 46.58% | 49.76% | 42.83% | 39.70% | 42.46% |
| Operating Expenses | |||||
| R&D Expenses | $0.06B | $0.08B | $0.04B | $0.04B | $0.01B |
| G&A Expenses | $0.08B | $0.27B | $0.08B | $0.08B | $0.06B |
| Total Operating Expenses | $0.57B | $0.70B | $0.62B | $0.68B | $0.58B |
| Operating Income | $0.23B | $0.14B | $0.09B | ($0.11B) | $0.04B |
| Operating Margin %(computed) | 13.28% | 8.17% | 5.41% | -7.83% | 3.01% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.04B | $0.03B |
| Interest Expense | $0.10B | $0.10B | $0.06B | $0.04B | $0.03B |
| Income Before Tax | $0.21B | $0.07B | $0.04B | ($0.15B) | $0.03B |
| Income Tax Expense | $0.01B | $0.04B | $0.05B | $0.02B | $0.01B |
| Net Income | $0.18B | $0.02B | ($0.01B) | ($0.17B) | $0.03B |
| Net Margin %(computed) | 10.80% | 1.46% | -0.83% | -11.93% | 1.81% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.54 | $0.21 | $-0.11 | $-1.42 | $0.22 |
| Wtd Avg Shares | 0.12B | 0.12B | 0.12B | 0.12B | 0.12B |
| EBITDA | $0.32B | $0.22B | $0.17B | ($0.01B) | $0.14B |
| EBITDA Margin %(computed) | 18.97% | 13.26% | 10.52% | -0.66% | 9.77% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Saudi Pharmaceutical Industries and Medical Appliances Corporation data
About Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) Income Statement
Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, 2070.SR reported revenue of $1.71B, gross profit of $0.79B (gross margin 46.58%), and net income of $0.18B — a net profit margin of 10.80%.
Frequently asked questions
2070.SR · 4 questionsSaudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) reported revenue of $1.71B for 2025, up 1.5% year-over-year.
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15